Key facts
- It has raised $29.1M; the latest was Later Stage VC in May 2025.
- Notable investors include Plug and Play Tech Center, US National Science Foundation, SOSV, Accel, U.S. Department of Energy — 26 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 26 names
- ·Watchlist + deal alerts for Zymochem
- ·The full record, as it builds
Funding rounds
No funding rounds for Zymochem are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zymochem
Developer of eco-friendly chemicals and processes using microbes designed to reduce carbon loss during chemical production. The company develops biosynthetic pathways, engineering novel microbes and establishes cost-advantaged bioprocesses for the biological conversion of sugars and other bio-based feedstocks into various industrial chemicals used in the manufacturing of consumer products to reduce carbon loss, enabling clients to lower production costs and improve cost-competitiveness.
- Sector
- Healthcare
- HQ
- San Leandro, CA, United States
- Founded
- 2013
- Employees
- 58
- Website
- zymochem.com/
- Ownership
- Privately Held (backing)
Zymochem doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zymochem shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zymochem in its N-PORT filings yet. We sweep new filings monthly.